Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Sep. 30, 2022 | Nov. 03, 2022 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Sep. 30, 2022 | |
Entity File Number | 001-39857 | |
Entity Registrant Name | EMPOWERMENT & INCLUSION CAPITAL I CORP. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 13-4055608 | |
Entity Address, Address Line One | 340 Madison Avenue | |
Entity Address, City or Town | New York | |
Entity Address State Or Province | NY | |
Entity Address, Postal Zip Code | 10173 | |
City Area Code | 212 | |
Local Phone Number | 468-8655 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Shell Company | true | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q3 | |
Entity Central Index Key | 0001825720 | |
Amendment Flag | false | |
Entity Ex Transition Period | false | |
Transition Report | false | |
Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant | |
Trading Symbol | EPWR.U | |
Security Exchange Name | NYSE | |
Class A common stock | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Class A common stock, par value $0.0001 per share | |
Trading Symbol | EPWR | |
Security Exchange Name | NYSE | |
Class A common stock subject to possible redemption | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 27,600,000 | |
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share | |
Trading Symbol | EPWR WS | |
Security Exchange Name | NYSE | |
Class B common stock | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 6,900,000 |
CONDENSED BALANCE SHEETS
CONDENSED BALANCE SHEETS - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 |
Current assets | ||
Cash | $ 232,205 | $ 98,035 |
Prepaid expenses | 157,617 | 532,138 |
Total current assets | 389,822 | 630,173 |
Investments held in Trust Account | 277,236,285 | 276,026,697 |
TOTAL ASSETS | 277,626,107 | 276,656,870 |
Current liabilities | ||
Accrued expenses | 249,065 | 473,362 |
Income taxes payable | 222,125 | |
Total current liabilities | 471,190 | 473,362 |
Working Capital Promissory Notes | 60,000 | 169,000 |
Deferred underwriting fee payable | 9,660,000 | 9,660,000 |
Warrant liabilities | 1,279,200 | 10,660,000 |
Total liabilities | 11,470,390 | 20,962,362 |
Commitments and contingencies | ||
Stockholders' Deficit | ||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | ||
Stock subscription receivable from stockholders | (5,000) | (5,000) |
Accumulated deficit | (10,828,826) | (20,301,182) |
Total Stockholders' Deficit | (10,833,136) | (20,305,492) |
TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' DEFICIT | 277,626,107 | 276,656,870 |
Class A common stock subject to possible redemption | ||
Current liabilities | ||
Class A common stock subject to possible redemption 27,600,000 shares at approximately $10.00 per share at September 30, 2022, and December 31, 2021 | 276,988,853 | 276,000,000 |
Class B common stock | ||
Stockholders' Deficit | ||
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,900,000 shares issued and outstanding at September 30, 2022, and December 31, 2021 | $ 690 | $ 690 |
CONDENSED BALANCE SHEETS (Paren
CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares | Sep. 30, 2022 | Dec. 31, 2021 |
Preferred stock, par value, (per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Class A common stock subject to possible redemption | ||
Temporary equity, shares outstanding | 27,600,000 | 27,600,000 |
Shares subject to possible redemption, per share | $ 10.03 | $ 10 |
Class B common stock | ||
Common shares, par value, (per share) | $ 0.0001 | $ 0.0001 |
Common shares, shares authorized | 20,000,000 | 20,000,000 |
Common shares, shares issued | 6,900,000 | 6,900,000 |
Common shares, shares outstanding | 6,900,000 | 6,900,000 |
CONDENSED STATEMENTS OF OPERATI
CONDENSED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Operating and formation costs | $ 292,045 | $ (932) | $ 963,919 | $ 641,613 |
(Loss) Income from operations | (292,045) | 932 | (963,919) | (641,613) |
Other income (expense): | ||||
Interest earned on investments held in Trust Account | 1,217,253 | 6,958 | 1,592,453 | 19,739 |
Transaction costs attributable to Warrant liabilities | (633,329) | |||
Change in fair value of Warrant liabilities | (426,400) | 213,200 | (9,380,800) | |
Change in fair value of Working Capital Promissory Notes | 20,000 | 89,000 | 734,000 | 89,000 |
Other income (expense), net | 1,663,653 | (117,242) | 11,707,253 | (524,590) |
Income (Loss) before provision for income taxes | 1,371,608 | (116,310) | 10,743,334 | (1,166,203) |
Provision for income taxes | 238,283 | 282,125 | ||
Net income (loss) | $ 1,133,325 | $ (116,310) | $ 10,461,209 | $ (1,166,203) |
Class A common stock | ||||
Other income (expense): | ||||
Basic weighted average shares outstanding | 27,600,000 | 27,600,000 | 27,600,000 | 26,391,241 |
Diluted weighted average shares outstanding | 27,600,000 | 27,600,000 | 27,600,000 | 26,391,241 |
Basic net income (loss) per share | $ 0.03 | $ 0 | $ 0.30 | $ (0.04) |
Diluted net income (loss) per share | $ 0.03 | $ 0 | $ 0.30 | $ (0.04) |
Class B common stock | ||||
Other income (expense): | ||||
Basic weighted average shares outstanding | 6,900,000 | 6,900,000 | 6,900,000 | 6,860,584 |
Diluted weighted average shares outstanding | 6,900,000 | 6,900,000 | 6,900,000 | 6,860,584 |
Basic net income (loss) per share | $ 0.03 | $ 0 | $ 0.30 | $ (0.04) |
Diluted net income (loss) per share | $ 0.03 | $ 0 | $ 0.30 | $ (0.04) |
CONDENSED STATEMENTS OF CHANGES
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($) | Class B common stock Common Stock | Additional Paid-in Capital | Stock Subscription Receivable from Stockholder | Accumulated Deficit | Total |
Balance at the beginning at Dec. 31, 2020 | $ 690 | $ 24,310 | $ (5,000) | $ (3,936) | $ 16,064 |
Balance at the beginning (in shares) at Dec. 31, 2020 | 6,900,000 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income (loss) | 2,635,922 | 2,635,922 | |||
Accretion of Class A common stock subject to possible redemption | (1,904,310) | (24,128,547) | (26,032,857) | ||
Sale of 7,520,000 Private Placement Warrants | 1,880,000 | 1,880,000 | |||
Balance at the end at Mar. 31, 2021 | $ 690 | (5,000) | (21,496,561) | (21,500,871) | |
Balance at the end (in shares) at Mar. 31, 2021 | 6,900,000 | ||||
Balance at the beginning at Dec. 31, 2020 | $ 690 | $ 24,310 | (5,000) | (3,936) | 16,064 |
Balance at the beginning (in shares) at Dec. 31, 2020 | 6,900,000 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income (loss) | (1,166,203) | ||||
Balance at the end at Sep. 30, 2021 | $ 690 | (5,000) | (25,298,686) | (25,302,996) | |
Balance at the end (in shares) at Sep. 30, 2021 | 6,900,000 | ||||
Balance at the beginning at Mar. 31, 2021 | $ 690 | (5,000) | (21,496,561) | (21,500,871) | |
Balance at the beginning (in shares) at Mar. 31, 2021 | 6,900,000 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income (loss) | (3,685,815) | (3,685,815) | |||
Balance at the end at Jun. 30, 2021 | $ 690 | (5,000) | (25,182,376) | (25,186,686) | |
Balance at the end (in shares) at Jun. 30, 2021 | 6,900,000 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income (loss) | (116,310) | (116,310) | |||
Balance at the end at Sep. 30, 2021 | $ 690 | (5,000) | (25,298,686) | (25,302,996) | |
Balance at the end (in shares) at Sep. 30, 2021 | 6,900,000 | ||||
Balance at the beginning at Dec. 31, 2021 | $ 690 | (5,000) | (20,301,182) | (20,305,492) | |
Balance at the beginning (in shares) at Dec. 31, 2021 | 6,900,000 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income (loss) | 6,869,860 | 6,869,860 | |||
Balance at the end at Mar. 31, 2022 | $ 690 | (5,000) | (13,431,322) | (13,435,632) | |
Balance at the end (in shares) at Mar. 31, 2022 | 6,900,000 | ||||
Balance at the beginning at Dec. 31, 2021 | $ 690 | (5,000) | (20,301,182) | (20,305,492) | |
Balance at the beginning (in shares) at Dec. 31, 2021 | 6,900,000 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income (loss) | 10,461,209 | ||||
Balance at the end at Sep. 30, 2022 | $ 690 | (5,000) | (10,828,826) | (10,833,136) | |
Balance at the end (in shares) at Sep. 30, 2022 | 6,900,000 | ||||
Balance at the beginning at Mar. 31, 2022 | $ 690 | (5,000) | (13,431,322) | (13,435,632) | |
Balance at the beginning (in shares) at Mar. 31, 2022 | 6,900,000 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income (loss) | 2,458,024 | 2,458,024 | |||
Accretion of Class A common stock subject to possible redemption | (61,751) | (61,751) | |||
Balance at the end at Jun. 30, 2022 | $ 690 | (5,000) | (11,035,049) | (11,039,359) | |
Balance at the end (in shares) at Jun. 30, 2022 | 6,900,000 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income (loss) | 1,133,325 | 1,133,325 | |||
Accretion of Class A common stock subject to possible redemption | (927,102) | (927,102) | |||
Balance at the end at Sep. 30, 2022 | $ 690 | $ (5,000) | $ (10,828,826) | $ (10,833,136) | |
Balance at the end (in shares) at Sep. 30, 2022 | 6,900,000 |
CONDENSED STATEMENTS OF CHANG_2
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) - Private Placement Warrants - shares | Mar. 31, 2021 | Jan. 12, 2021 |
Sale of private placement warrants (in shares) | 7,520,000 | |
Private Placement | ||
Sale of private placement warrants (in shares) | 7,520,000 | 7,520,000 |
CONDENSED STATEMENTS OF CASH FL
CONDENSED STATEMENTS OF CASH FLOWS - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Cash flows from operating activities: | |||||
Net income (loss) | $ 10,461,209 | $ (1,166,203) | |||
Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||||
Change in fair value of Working Capital Promissory Notes | $ (20,000) | $ (89,000) | (734,000) | (89,000) | |
Change in fair value of Warrant liabilities | (426,400) | 213,200 | (9,380,800) | ||
Transaction costs attributable to Warrant liabilities | 633,329 | ||||
Interest earned on investments held in Trust Account | (1,217,253) | (6,958) | (1,592,453) | (19,739) | |
Changes in operating assets and liabilities: | |||||
Prepaid expenses | 374,521 | (667,672) | |||
Accrued expenses | (224,297) | 229,875 | |||
Income taxes payable | 222,125 | ||||
Net cash used in operating activities | (873,695) | (1,079,410) | |||
Cash flows from investing activities: | |||||
Cash withdrawn from Trust Account to pay franchise and income taxes | 382,865 | $ 0 | |||
Investment of cash in Trust Account | (276,000,000) | ||||
Net cash provided by (used in) investing activities | 382,865 | (276,000,000) | |||
Cash flows from financing activities: | |||||
Proceeds from sale of Units, net of underwriting discounts paid | 270,480,000 | ||||
Proceeds from sale of Private Placement Warrants | 7,520,000 | ||||
Repayment of Promissory Notes - related party | (128,302) | ||||
Proceeds from Working Capital Promissory Notes | 625,000 | 275,000 | |||
Payment of offering costs | (987,884) | ||||
Net cash provided by financing activities | 625,000 | 277,158,814 | |||
Net change in cash | 134,170 | 79,404 | |||
Cash - beginning of period | 98,035 | ||||
Cash - end of period | $ 232,205 | $ 79,404 | 232,205 | 79,404 | $ 98,035 |
Supplemental cash flow information: | |||||
Cash paid for income taxes | $ 60,000 | ||||
Non-cash investing and financing activities: | |||||
Offering costs paid through promissory note - related party | 11,919 | ||||
Deferred underwriting fee payable | $ 9,660,000 |
DESCRIPTION OF ORGANIZATION AND
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | 9 Months Ended |
Sep. 30, 2022 | |
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | |
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Empowerment & Inclusion Capital I Corp. (the “Company”) was initially formed as a Delaware limited liability company on May 29, 1999 under the name of PHX Capital LLC. On September 17, 2020, the Company converted from a limited liability company to a Delaware C Corporation and changed its name to Empowerment & Inclusion Capital I Corp. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Initial Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating an Initial Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2022, the Company had not commenced any operations. All activity through September 30, 2022 relates to the Company’s formation, the initial public offering (“IPO”), which is described below, and subsequent to the IPO, public company-related activities for legal, financial reporting, accounting and auditing compliance and the identification of a target company for an Initial Business Combination. The Company will not generate any operating revenues until after the completion of an Initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the IPO. The registration statement for the Company’s IPO was declared effective on January 7, 2021. On January 12, 2021, the Company consummated the IPO of 27,600,000 units (the “Units”), which includes the full exercise by the underwriter of its over-allotment option in the amount of 3,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276,000,000, which is described in Note 3. Each Unit consists of one share of Class A common stock (the “Public Shares”) and one-half Simultaneously with the closing of the IPO, the Company consummated the sale of 7,520,000 warrants (the “Private Placement Warrants” and together with the Public Warrants, the “Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to PNC Investment Capital Corp. (“PNCIC”), Jefferies Financial Group Inc. (“Jefferies” and together with PNCIC, the “Sponsors”) and the Company’s Chief Executive Officer (“CEO”), Harold Ford Jr., generating gross proceeds of $7,520,000, which is described in Note 4. Transaction costs relating to the foregoing amounted to $16,316,186, consisting of $5,520,000 in cash underwriting fees, $9,660,000 and $415,804 of deferred underwriting and legal fees, respectively, with such deferred fees payable contingent upon the close of an Initial Business Combination, and $720,382 of other offering costs. During the year ended December 31, 2021, the Company paid $150,000 in settlement of the outstanding deferred legal fee. Following the closing of the IPO on January 12, 2021, an amount of $276,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of an Initial Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all net proceeds are intended to be applied generally toward consummating an Initial Business Combination. There is no assurance that the Company will be able to complete an Initial Business Combination successfully. The Company must complete one or more initial business combinations with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). The Company will only complete an Initial Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of an Initial Business Combination either (i) in connection with a stockholder meeting called to approve the Initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of an Initial Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights upon the completion of an Initial Business Combination with respect to the Warrants. The Company will only proceed with an Initial Business Combination if the Company has net tangible assets of at least $5,000,001 following any related redemptions and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Initial Business Combination. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing an Initial Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with an Initial Business Combination, the Sponsors have agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased by them during or after the IPO in favor of approving an Initial Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. Notwithstanding the foregoing, if the Company seeks stockholder approval of an Initial Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The Sponsors have agreed (i) to waive their redemption rights with respect to the Founder Shares and Public Shares held by them in connection with the completion of an Initial Business Combination and (ii) not to propose an amendment to the Certificate of Incorporation (a) to modify the substance or timing of the Company’s obligation to allow redemptions in connection with an Initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete an Initial Business Combination within the Combination Period (as defined below) or (b) with respect to any other provision relating to stockholders’ rights or pre-business combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company will have until January 12, 2023 (absent any extensions of such period with stockholder approval) to complete an Initial Business Combination (the “Combination Period”). If the Company is unable to complete an Initial Business Combination within the Combination Period, or if its stockholders have not approved an extension, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten The Sponsors have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete an Initial Business Combination within the Combination Period. However, if the Sponsors acquired Public Shares in or after the IPO, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete an Initial Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event that the Company does not complete an Initial Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsors have agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable; provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account, nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsors will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsors will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity, Capital Resources and Going Concern As of September 30, 2022, the Company had $232,205 in its operating bank account and working capital of $166,064, excluding certain tax liabilities payable with interest earned on the funds held in Trust. To fund working capital deficiencies or finance transaction costs in connection with an Initial Business Combination, the Sponsors or an affiliate of the Sponsors, or certain of the Company’s officers and directors, may but are not obligated to loan the Company additional funds as may be required (the “Working Capital Loans”), of which up to $1,000,000 was committed by the Sponsors on January 7, 2021, when the Company issued convertible promissory notes in favor of the Sponsors pursuant to which the Company may borrow up to an aggregate principal amount of $1,000,000 for working capital (the “Working Capital Promissory Notes”) (see Note 5). As of September 30, 2022 and December 31, 2021, the Company has drawn upon the Working Capital Promissory Notes in amounts totaling $1,000,000 and $375,000, respectively, with a fair value of $60,000 and $169,000, respectively (see Note 9). If the Company completes an Initial Business Combination, the Company may repay the Working Capital Loans, including the Working Capital Promissory Notes, out of the proceeds of the Trust Account released to the Company, or convert up to $1.5 million into warrants (see Note 5). If an Initial Business Combination is not completed, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Company may raise additional capital through loans or additional investments from the Sponsors or its stockholders, officers, directors or third parties. The Company’s officers and directors and the Sponsors may but are not obligated to (except as described above), loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. The Company believes it will require additional borrowing capacity from the Sponsors or an affiliate of the Sponsors, or certain of the Company’s officers and directors, to meet its needs through the earlier of the consummation of an Initial Business Combination or at least one year from the date that the unaudited condensed financial statements were issued. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update 2014-15, Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern, the Company has until January 12, 2023, to consummate an Initial Business Combination, absent any extensions of such period, which would require stockholder approval. It is uncertain that the Company will be able to consummate an Initial Business Combination by this time. If the Company is unable to complete an Initial Business Combination, or obtain such an extension, by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition described above and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 12, 2023. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 9 Months Ended |
Sep. 30, 2022 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in unaudited condensed financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as filed with the SEC on March 9, 2022 (the “Form 10-K”). The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Two of the more significant accounting estimates included in these unaudited condensed financial statements are the determination of the fair value of the Warrant liabilities and the Working Capital Promissory Notes. Accordingly, the actual results could differ significantly from those estimates. Offering Costs Offering costs consisted of legal, accounting and other expenses incurred through the balance sheet date that were directly related to the IPO. Offering costs amounted to $16,316,186, of which $15,682,857 was charged to temporary equity upon the completion of the IPO and $633,329 was expensed to the condensed statements of operations (see Note 1). Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in FASB Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity (“ASC 480”). Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ deficit. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2022 and December 31, 2021, Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets is reconciled in the following table: Gross proceeds $ 276,000,000 Less: Proceeds Allocated to Public Warrants (10,350,000) Class A common stock issuance costs (15,682,857) Plus: Accretion of carrying value to redemption value 26,032,857 Class A common stock subject to possible redemption, December 31, 2021 276,000,000 Plus: Accretion of carrying value to redemption value 988,853 Class A common stock subject to possible redemption, September 30, 2022 $ 276,988,853 Warrant Liabilities The Company accounts for Warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and FASB ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480 and meet all the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company accounts for the Warrants as liabilities in accordance with the guidance contained in FASB ASC Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40”), under which the Warrants do not meet the criteria for equity treatment and are measured at fair value at inception and on a recurring basis, with changes in fair value recorded in the statement of operations (see Note 9). For issued or modified warrants that meet all the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the Warrants was estimated using a Monte Carlo simulation approach (see Note 9). For periods subsequent to the detachment of the Public Warrants from the Units, the closing price of the Public Warrants was used as the fair value as of each relevant date. Convertible Working Capital Promissory Notes The Company accounts for its convertible Working Capital Promissory Notes under ASC 815. Under section ASC 815-15-25, the election can be made at the inception of a financial instrument to account for the instrument under the fair value option under FASB ASC Topic 825, Financial Instruments (“ASC 825”). The Company has made such election for its Working Capital Promissory Notes. Using the fair value option, the Working Capital Promissory Notes are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the Working Capital Promissory Notes are recognized as a non-cash gain or loss on the condensed statements of operations (see Note 9). Income Taxes The Company accounts for income taxes under FASB ASC Topic 740, Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it. The effective tax rate differs from the statutory tax rate of 21% for the three months and nine months ended September 30, 2022 and 2021 due to changes in fair value in Warrant liability, changes in fair value in the Working Capital Promissory Notes, and changes in the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Income and losses are shared pro rata between the two classes of shares. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income (loss) per share does not consider the effect of the Warrants issued in connection with (i) the IPO, (ii) the private placement, or (iii) the convertible feature of the Working Capital Loans since the exercise of the Warrants is contingent upon the occurrence of future events. The Warrants are exercisable to purchase 21,320,000 shares of Class A common stock in the aggregate. The Working Capital Loans made to the Company may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant. As of September 30, 2022 and 2021, the Company did not have any other dilutive securities or other contracts that could potentially be exercised or converted into common stock and then share in the earnings of the Company. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Class A Class B Class A Class B Class A Class B Class A Class B Numerator: Allocation of net income (loss) $ 906,660 $ 226,665 $ (93,048) $ (23,262) $ 8,368,967 $ 2,092,242 $ (925,590) $ (240,613) Denominator Basic and diluted weighted average shares outstanding 27,600,000 6,900,000 27,600,000 6,900,000 27,600,000 6,900,000 26,391,241 6,860,584 Basic and diluted net income (loss) per common share $ 0.03 $ 0.03 $ (0.00) (0.00) $ 0.30 $ 0.30 $ (0.04) $ (0.04) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, Fair Value Measurement (“ASC 820”), approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, except for the Warrant liabilities and the Working Capital Promissory Notes (see Note 9). Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. |
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING | 9 Months Ended |
Sep. 30, 2022 | |
INITIAL PUBLIC OFFERING | |
INITIAL PUBLIC OFFERING | NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the IPO, the Company sold 27,600,000 Units, which includes a full exercise by the underwriters of their over-allotment option in the amount of 3,600,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-half |
PRIVATE PLACEMENT
PRIVATE PLACEMENT | 9 Months Ended |
Sep. 30, 2022 | |
PRIVATE PLACEMENT. | |
PRIVATE PLACEMENT | NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the IPO, the Sponsors and the Company’s CEO purchased an aggregate of 7,520,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant ($7,520,000 in the aggregate) from the Company in a private placement. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete an Initial Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. Pursuant to a letter agreement entered into between the Sponsors and the Company’s CEO dated September 21, 2020, the Sponsors transferred to the CEO a number of Private Placement Warrants equal to 20% of the outstanding Private Placement Warrants acquired by the Sponsors upon consummation of the IPO (the “CEO Warrants”). Unless otherwise determined by Board, if prior to the consummation of the Initial Business Combination the CEO (i) resigns from the Company as CEO or (ii) is removed or otherwise terminated by the Board, the CEO Warrants shall be forfeited at no cost back to the Sponsors (on a pro rata basis). No shares of Class A common stock of the Company will be delivered pursuant to any exercise of a CEO Warrant until payment in full of the exercise price is received by the Company and the holder has paid to the Company an amount equal to any taxes required to be withheld or paid upon exercise of the CEO Warrants. Pursuant to a letter agreement entered into between the Sponsors and the Company’s Chief Financial Officer (“CFO”), Virginia Henkels, dated November 4, 2020, the Sponsors transferred to the CFO a number of Private Placement Warrants equal to 7% of the outstanding Private Placement Warrants acquired by the Sponsors upon consummation of the IPO (the “CFO Warrants”). Unless otherwise determined by the Board, if prior to the consummation of the Initial Business Combination the CFO (i) resigns from the Company as CFO, (ii) is removed or otherwise terminated by the Board or (iii) dies, the CFO Warrants shall be forfeited at no cost back to the Sponsors (on a pro rata basis). No shares of Class A common stock of the Company will be delivered pursuant to any exercise of a CFO Warrant until payment in full of the exercise price is received by the Company and the holder has paid to the Company an amount equal to any taxes required to be withheld or paid upon exercise of the CFO Warrants. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 9 Months Ended |
Sep. 30, 2022 | |
RELATED PARTY TRANSACTIONS | |
RELATED PARTY TRANSACTIONS | NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares In 1999, Jefferies subscribed for an aggregate of 1,000 shares of the Company’s membership interests for $5,000. On September 17, 2020, in connection with the Company’s conversion to a C Corporation, the Company converted the 1,000 membership interests owned by Jefferies into 1,150,000 shares of the Company’s Class B common stock. Also, on September 17, 2020, PNCIC paid $20,000 to cover certain offering costs of the Company in consideration for 4,600,000 shares of the Company’s Class B common stock. As a result, there were 5,750,000 shares of Class B common stock issued and outstanding Excluding the effect of the stock split discussed above, on September 21, 2020, PNCIC transferred 1,150,000 Founder Shares to the Company’s CEO. On November 4, 2020, PNCIC transferred 301,875 Founder Shares to the Company’s CFO, and Jefferies transferred 100,625 Founder Shares to the CFO. The Founder Shares included an aggregate of up to 900,000 shares subject to forfeiture, to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the number of Founder Shares would equal, on an as-converted basis, approximately 20% of the Company’s issued and outstanding common stock after the IPO. As a result of the underwriters’ election to fully exercise their over-allotment option, no Founder Shares are currently subject to forfeiture. The Sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (i) one year after the completion of an Initial Business Combination or (ii) subsequent to an Initial Business Combination, (a) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after an Initial Business Combination, or (b) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property. Administrative Services Agreement The Company entered into an agreement on January 12, 2021, commencing February 1, 2021 through the earlier of the Company’s consummation of a business combination and its liquidation, to pay an affiliate of PNCIC approximately $10,000 per month for office space, utilities, and secretarial and administrative support. For the three and nine months ended September 30, 2022, the Company incurred and paid $29,211 and $87,633, respectively, in fees for these services. For the three and nine months ended September 30, 2021, the Company incurred and paid $29,211 and $77,896, respectively, in fees for these services. Promissory Note — Related Party On September 17, 2020, the Company issued unsecured promissory notes in favor of the Sponsors (the “Promissory Notes”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Notes were non-interest bearing and payable on the earlier of (i) March 31, 2021 or (ii) the consummation of the IPO. The outstanding balance under the Promissory Notes of $128,302 was repaid at the closing of the IPO on January 12, 2021 and is no longer available. Related Party Loans On January 7, 2021, the Company issued the Working Capital Promissory Notes in favor of the Sponsors pursuant to which the Company may borrow up to an aggregate principal amount of $1,000,000 for working capital. In addition, to finance transaction costs in connection with a business combination, the Sponsors or an affiliate of the Sponsors, or certain of the Company’s officers and directors, may but are not obligated to provide the Company with additional Working Capital Loans. The Working Capital Promissory Notes are non-interest bearing and payable upon the consummation of an Initial Business Combination. The Working Capital Promissory Notes are convertible, at the lender’s option, into warrants to purchase shares of Class A common stock at a conversion price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Given this conversion feature, the Company has elected the fair value option for recording the Working Capital Promissory Notes (see Note 9). On August 20, 2021, the Company drew an aggregate of $275,000 on the Working Capital Promissory Notes. Subsequently, on December 15, 2021, the Company drew an aggregate of $100,000 on the Working Capital Promissory Notes, bringing the outstanding balance as of December 31, 2021 to $375,000 with a fair value of $169,000 (see Note 9). On January 4, 2022, the Company drew an aggregate of $400,000 on the Working Capital Promissory Notes, and on March 23, 2022 drew the remaining $225,000, bringing the outstanding balance on the Working Capital Promissory Notes as of September 30, 2022 to $1,000,000 with a fair value of $60,000 (see Note 9). If the Company completes an Initial Business Combination, the Company will repay the Working Capital Loans, including the Working Capital Promissory Notes, out of the proceeds of the Trust Account released to the Company. If an Initial Business Combination is not completed, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a business combination, without interest, or at the lender’s discretion, up to $1,500,000 of such Working Capital Loans made to the Company may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. As of September 30, 2022, the Company drew an aggregate of $1,000,000 on the Working Capital Promissory Notes, of which $750,000 was drawn from a Working Capital Promissory Note with PNCIC and $250,000 was drawn from a Working Capital Promissory Note with Jefferies. Given the convertible feature contained within the Working Capital Promissory Notes, the Company has elected the fair value option for accounting purposes and recorded a change in fair value of $20,000 and $734,000 related to the Working Capital Promissory Notes for the three and nine months ended September 30, 2022, respectively, as described in Note 9. Initial Public Offering Jefferies, one of our Sponsors, acted as a lead underwriter in our IPO. Solebury Capital LLC, an affiliate of one of our Sponsors, acted as a financial advisor in connection with our IPO. We have agreed to pay Solebury Capital LLC up to 3.5% of the gross spread earned by the underwriters for their services. As of September 30, 2022, we paid Jefferies $5,520,000 of underwriting fees of which Solebury Capital LLC received $193,200. An additional $9,660,000 of underwriting fees have been deferred and are payable contingent upon the closing of an Initial Business Combination. We are under no obligation to engage any of the underwriters or financial advisors that provided services to us in our IPO to provide any services for us in the future, including with respect to a business combination, although we are not prohibited from doing so. Any of the underwriters or financial advisors that provided services to us in our IPO may introduce us to potential target businesses or assist us in raising additional capital in the future. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 9 Months Ended |
Sep. 30, 2022 | |
COMMITMENTS AND CONTINGENCIES. | |
COMMITMENTS AND CONTINGENCIES | NOTE 6. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the continuing impacts of the pandemic could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, a specific material adverse impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Inflation Reduction Act of 2022 On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, whether in connection with an Initial Business Combination, the solicitation of stockholders to extend the time period that the Company has to complete an Initial Business Combination, or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with an Initial Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Initial Business Combination, extension or otherwise, (ii) the structure of an Initial Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with an Initial Business Combination (or equity otherwise issued not in connection with an Initial Business Combination but issued within the same taxable year of an Initial Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete an Initial Business Combination and in the Company’s ability to complete an Initial Business Combination. Registration Rights Pursuant to a registration rights agreement entered into on January 12, 2021, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Company’s Class A common stock). The holders of at least 15% of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, these holders will have certain “piggy-back” registration rights to include such securities in other registration statements filed by the Company and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the costs and expenses incurred in connection with filing any such registration statements. Notwithstanding the foregoing, Jefferies may not exercise its demand and “piggyback” registration rights after five and seven years , respectively, from the effective date of the registration statement and may not exercise its demand rights on more than one occasion. Underwriting and Legal Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $9,660,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an Initial Business Combination, subject to the terms of the underwriting agreement. |
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT | 9 Months Ended |
Sep. 30, 2022 | |
STOCKHOLDERS' DEFICIT | |
STOCKHOLDERS' DEFICIT | NOTE 7. STOCKHOLDERS’ DEFICIT Preferred Stock — Class A Common Stock Class B Common Stock Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as otherwise required by law; provided that only holders of Class B common stock will have the right to vote on the election of directors prior to the Initial Business Combination. The shares of Class B common stock will automatically convert into Class A common stock concurrently with or immediately following the consummation of an Initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with an Initial Business Combination, the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by Public Stockholders), including the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued by the Company in connection with or in relation to the consummation of an Initial Business Combination, excluding any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued or to be issued to any seller in an Initial Business Combination and any private placement-equivalent warrants issued to the Sponsors, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. |
WARRANTS
WARRANTS | 9 Months Ended |
Sep. 30, 2022 | |
WARRANTS. | |
WARRANTS | NOTE 8. WARRANTS As of September 30, 2022 and December 31, 2021, there were 13,800,000 Public Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (i) 30 days after the completion of an Initial Business Combination and (ii) 12 months from the closing of the IPO. The Public Warrants will expire five years after the completion of an Initial Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a Warrant and will have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a Warrant unless Class A common stock issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Warrants. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of an Initial Business Combination, the Company will use its best efforts to file with the SEC a registration statement registering the issuance of the shares of Class A common stock issuable upon exercise of the Warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A common stock until the Warrants expire or are redeemed, as specified in the warrant agreement; provided, however, that the Private Placement Warrants issued to Jefferies will not be exercisable more than five years from the effective date of the registration statement in accordance with FINRA rules. If a registration statement covering the shares of Class A common stock issuable upon exercise of the Warrants is not effective by the 60 th Redemption of warrants when the price per share of Class A common stock equals or exceeds $ 18.00 . ● in whole and not in part; ● at a price of $0.01 per Warrant; ● upon not less than 30 days ’ prior written notice of redemption to each Warrant holder; and ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. If and when the Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of common stock upon exercise of the Warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. Redemption of Warrants when the price per share of Class A common stock equals or exceeds $10.00 . ● in whole and not in part; ● at a price of $0.10 per Warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the shares of Class A common stock; ● if the closing price of the shares of Class A common stock for any 20 trading days within a 30 trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Warrant holders is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the Warrants may be adjusted in certain circumstances, including in the event of a stock dividend, recapitalization, reorganization, merger or consolidation. However, except as described below, the Warrants will not be adjusted for the issuance of Class A common stock at a price below their exercise price. Additionally, in no event will the Company be required to net cash settle the Warrants. If the Company is unable to complete an Initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Warrants will not receive any of such funds with respect to their Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such Warrants. Accordingly, the Warrants may expire worthless. In addition, if the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of an Initial Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Board, and in the case of any such issuance to the Company’s initial stockholders or their respective affiliates, without taking into account any Founder Shares held by the Sponsors, as applicable, prior to such issuance) (the “Newly Issued Price”), the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the Newly Issued Price. As of September 30, 2022 and December 31, 2021, there were 7,520,000 Private Placement Warrants outstanding. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the IPO, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until after the completion of an Initial Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. |
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS | 9 Months Ended |
Sep. 30, 2022 | |
FAIR VALUE MEASUREMENTS | |
FAIR VALUE MEASUREMENTS | NOTE 9. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: September 30, December 31, Description Level 2022 2021 Assets: Investments held in Trust Account - U.S. Treasury Securities Money Market Fund 1 $ 277,236,285 $ 276,026,697 Liabilities: Working Capital Promissory Notes 2 $ 60,000 $ 169,000 Warrant liability - Public Warrants 1 $ 828,000 $ 6,900,000 Warrant liability - Private Placement Warrants 2 451,200 3,760,000 Total Warrant liabilities $ 1,279,200 $ 10,660,000 At September 30, 2022 and December 31, 2021, assets held in the Trust Account were comprised of $277,236,285 and $276,026,697, respectively, in money market funds which are invested primarily in U.S. Treasury Securities, which are presented on the condensed balance sheet at fair value. Through September 30, 2022 and December 31, 2021, the Company had $382,865 and $0 withdrawals of interest earned on the Trust Account, respectively. The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are measured at fair value at inception and on a recurring basis, with changes in fair value recorded in the statements of operations. At issuance, the Warrant liability for the Warrants was valued as of January 12, 2021 using a Monte Carlo simulation, which is considered to be a Level 3 fair value measurement. Subsequent to the detachment of the Public Warrants from the Units, the Public Warrants are valued based on the quoted market price, under the ticker EPWR WS, which is a Level 1 fair value measurement. The Private Placement Warrants have substantially the same terms as the Public Warrants, and therefore are valued based on the quoted market price of the Public Warrants as of September 30, 2022 and December 31, 2021. However, since the Private Placement Warrants are not actively traded, they are listed as a Level 2 in the fair value hierarchy table above. The following table presents the changes in the fair value of Level 3 Warrant liabilities: Private Warrant Placement Public Liabilities Initial measurement on January 12, 2021 $ 5,640,000 $ 10,350,000 $ 15,990,000 Transfer to Level 1 during the three months ended March 31, 2021 — (10,350,000) (10,350,000) Change in fair value of Private Placement Warrants from January 12 to June 30, 2021 (75,200) — (75,200) Transfer to Level 2 during the three months ended September 30, 2021 (5,564,800) — (5,564,800) Fair value of Level 3 Warrant liabilities as of December 31, 2021 $ — $ — $ — Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement during the year ended December 31, 2021 was $10,350,000 at the time of transfer. The estimated fair value of the Private Placement Warrants transferred from a Level 3 measurement to a Level 2 fair value measurement during the year ended December 31, 2021 was $5,564,800 at the time of transfer. There were no transfers to/from Level 3 during the three- and nine-month period ended September 30, 2022. The Company elected the fair value option for recording the Working Capital Promissory Notes. The Working Capital Promissory Notes are convertible into warrants identical to the Private Placement Warrants. As noted above, similar to the Private Placement Warrants, as of September 30, 2022, the Working Capital Promissory Notes were valued based on the quoted market price of the Public Warrants as if they had been converted to warrants. However, they are not actively traded, and as such are listed as a Level 2 in the fair value hierarchy table above. The following table presents the changes in the fair value of the Level 2 Working Capital Promissory Notes: 2022 2021 Fair value as of January 1 $ 169,000 $ — Proceeds received from Working Capital Promissory Notes 625,000 — Change in fair value (604,000) — Fair value as of March 31 190,000 — Change in fair value (110,000) — Fair value as of June 30 80,000 — Proceeds received from Working Capital Promissory Notes — 275,000 Change in fair value (20,000) (89,000) Fair value as of September 30 $ (60,000) 186,000 Proceeds received from Working Capital Promissory Notes 100,000 Change in fair value (117,000) Fair value as of December 31 $ 169,000 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 9 Months Ended |
Sep. 30, 2022 | |
SUBSEQUENT EVENTS | |
SUBSEQUENT EVENTS | NOTE 10. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the condensed financial statements. |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 9 Months Ended |
Sep. 30, 2022 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in unaudited condensed financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as filed with the SEC on March 9, 2022 (the “Form 10-K”). The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Two of the more significant accounting estimates included in these unaudited condensed financial statements are the determination of the fair value of the Warrant liabilities and the Working Capital Promissory Notes. Accordingly, the actual results could differ significantly from those estimates. |
Offering Costs | Offering Costs Offering costs consisted of legal, accounting and other expenses incurred through the balance sheet date that were directly related to the IPO. Offering costs amounted to $16,316,186, of which $15,682,857 was charged to temporary equity upon the completion of the IPO and $633,329 was expensed to the condensed statements of operations (see Note 1). |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021. |
Class A Common Stock Subject to Possible Redemption | Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in FASB Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity (“ASC 480”). Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ deficit. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2022 and December 31, 2021, Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets is reconciled in the following table: Gross proceeds $ 276,000,000 Less: Proceeds Allocated to Public Warrants (10,350,000) Class A common stock issuance costs (15,682,857) Plus: Accretion of carrying value to redemption value 26,032,857 Class A common stock subject to possible redemption, December 31, 2021 276,000,000 Plus: Accretion of carrying value to redemption value 988,853 Class A common stock subject to possible redemption, September 30, 2022 $ 276,988,853 |
Warrant Liabilities | Warrant Liabilities The Company accounts for Warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and FASB ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480 and meet all the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company accounts for the Warrants as liabilities in accordance with the guidance contained in FASB ASC Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40”), under which the Warrants do not meet the criteria for equity treatment and are measured at fair value at inception and on a recurring basis, with changes in fair value recorded in the statement of operations (see Note 9). For issued or modified warrants that meet all the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the Warrants was estimated using a Monte Carlo simulation approach (see Note 9). For periods subsequent to the detachment of the Public Warrants from the Units, the closing price of the Public Warrants was used as the fair value as of each relevant date. |
Convertible Working Capital Promissory Notes | Convertible Working Capital Promissory Notes The Company accounts for its convertible Working Capital Promissory Notes under ASC 815. Under section ASC 815-15-25, the election can be made at the inception of a financial instrument to account for the instrument under the fair value option under FASB ASC Topic 825, Financial Instruments (“ASC 825”). The Company has made such election for its Working Capital Promissory Notes. Using the fair value option, the Working Capital Promissory Notes are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the Working Capital Promissory Notes are recognized as a non-cash gain or loss on the condensed statements of operations (see Note 9). |
Income Taxes | Income Taxes The Company accounts for income taxes under FASB ASC Topic 740, Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2022 and December 31, 2021, the Company’s deferred tax asset had a full valuation allowance recorded against it. The effective tax rate differs from the statutory tax rate of 21% for the three months and nine months ended September 30, 2022 and 2021 due to changes in fair value in Warrant liability, changes in fair value in the Working Capital Promissory Notes, and changes in the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. |
Net Income (Loss) per Common Share | Net Income (Loss) per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Income and losses are shared pro rata between the two classes of shares. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income (loss) per share does not consider the effect of the Warrants issued in connection with (i) the IPO, (ii) the private placement, or (iii) the convertible feature of the Working Capital Loans since the exercise of the Warrants is contingent upon the occurrence of future events. The Warrants are exercisable to purchase 21,320,000 shares of Class A common stock in the aggregate. The Working Capital Loans made to the Company may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant. As of September 30, 2022 and 2021, the Company did not have any other dilutive securities or other contracts that could potentially be exercised or converted into common stock and then share in the earnings of the Company. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Class A Class B Class A Class B Class A Class B Class A Class B Numerator: Allocation of net income (loss) $ 906,660 $ 226,665 $ (93,048) $ (23,262) $ 8,368,967 $ 2,092,242 $ (925,590) $ (240,613) Denominator Basic and diluted weighted average shares outstanding 27,600,000 6,900,000 27,600,000 6,900,000 27,600,000 6,900,000 26,391,241 6,860,584 Basic and diluted net income (loss) per common share $ 0.03 $ 0.03 $ (0.00) (0.00) $ 0.30 $ 0.30 $ (0.04) $ (0.04) |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, Fair Value Measurement (“ASC 820”), approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, except for the Warrant liabilities and the Working Capital Promissory Notes (see Note 9). |
Recent Accounting Standards | Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Schedule of reconciliation of common stock subject to possible redemption | Gross proceeds $ 276,000,000 Less: Proceeds Allocated to Public Warrants (10,350,000) Class A common stock issuance costs (15,682,857) Plus: Accretion of carrying value to redemption value 26,032,857 Class A common stock subject to possible redemption, December 31, 2021 276,000,000 Plus: Accretion of carrying value to redemption value 988,853 Class A common stock subject to possible redemption, September 30, 2022 $ 276,988,853 |
Schedule of calculation of basic and diluted net income (loss) per common share | The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Class A Class B Class A Class B Class A Class B Class A Class B Numerator: Allocation of net income (loss) $ 906,660 $ 226,665 $ (93,048) $ (23,262) $ 8,368,967 $ 2,092,242 $ (925,590) $ (240,613) Denominator Basic and diluted weighted average shares outstanding 27,600,000 6,900,000 27,600,000 6,900,000 27,600,000 6,900,000 26,391,241 6,860,584 Basic and diluted net income (loss) per common share $ 0.03 $ 0.03 $ (0.00) (0.00) $ 0.30 $ 0.30 $ (0.04) $ (0.04) |
FAIR VALUE MEASUREMENTS (Tables
FAIR VALUE MEASUREMENTS (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
FAIR VALUE MEASUREMENTS | |
Schedule of Company's assets and liabilities that are measured at fair value on a recurring basis | September 30, December 31, Description Level 2022 2021 Assets: Investments held in Trust Account - U.S. Treasury Securities Money Market Fund 1 $ 277,236,285 $ 276,026,697 Liabilities: Working Capital Promissory Notes 2 $ 60,000 $ 169,000 Warrant liability - Public Warrants 1 $ 828,000 $ 6,900,000 Warrant liability - Private Placement Warrants 2 451,200 3,760,000 Total Warrant liabilities $ 1,279,200 $ 10,660,000 |
Warrants | |
FAIR VALUE MEASUREMENTS | |
Schedule of change in the fair value | Private Warrant Placement Public Liabilities Initial measurement on January 12, 2021 $ 5,640,000 $ 10,350,000 $ 15,990,000 Transfer to Level 1 during the three months ended March 31, 2021 — (10,350,000) (10,350,000) Change in fair value of Private Placement Warrants from January 12 to June 30, 2021 (75,200) — (75,200) Transfer to Level 2 during the three months ended September 30, 2021 (5,564,800) — (5,564,800) Fair value of Level 3 Warrant liabilities as of December 31, 2021 $ — $ — $ — |
Working Capital Promissory Notes | |
FAIR VALUE MEASUREMENTS | |
Schedule of change in the fair value | 2022 2021 Fair value as of January 1 $ 169,000 $ — Proceeds received from Working Capital Promissory Notes 625,000 — Change in fair value (604,000) — Fair value as of March 31 190,000 — Change in fair value (110,000) — Fair value as of June 30 80,000 — Proceeds received from Working Capital Promissory Notes — 275,000 Change in fair value (20,000) (89,000) Fair value as of September 30 $ (60,000) 186,000 Proceeds received from Working Capital Promissory Notes 100,000 Change in fair value (117,000) Fair value as of December 31 $ 169,000 |
DESCRIPTION OF ORGANIZATION A_2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) | 9 Months Ended | 12 Months Ended | ||||
Jan. 12, 2021 USD ($) $ / shares shares | Sep. 17, 2020 item | Sep. 30, 2022 USD ($) | Sep. 30, 2021 USD ($) | Dec. 31, 2021 USD ($) | Jan. 07, 2021 USD ($) | |
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||||||
Condition for future business combination number of businesses minimum | item | 1 | |||||
Proceeds from sale of Private Placement Warrants | $ 7,520,000 | |||||
Transaction costs | $ 16,316,186 | |||||
Underwriting fees | 5,520,000 | |||||
Deferred underwriting fee payable | 9,660,000 | $ 9,660,000 | $ 9,660,000 | |||
Deferred legal fee payable | 415,804 | |||||
Other offering costs | $ 720,382 | |||||
Payments for deferred legal fees | 150,000 | |||||
Investment of cash into trust account | 276,000,000 | |||||
Threshold minimum aggregate fair market value as a percentage of the net assets held in the trust account | 80% | |||||
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination | 50% | |||||
Minimum net tangible assets upon consummation of business combination | $ 5,000,001 | |||||
Threshold percentage of public shares subject to redemption without company's prior written consent | 15% | |||||
Obligation to redeem Public Shares if entity does not complete a business combination (as a percent) | 100% | |||||
Threshold business days for redemption of public shares | 10 days | |||||
Maximum allowed dissolution expenses | $ 100,000 | |||||
Cash in operating bank account | 232,205 | 98,035 | ||||
Working capital | 166,064 | |||||
Working capital loan committed by sponsors | 1,000,000 | |||||
Proceeds from Working Capital Promissory Notes | 625,000 | $ 275,000 | ||||
Fair value of outstanding balance | 60,000 | 169,000 | ||||
Private Placement Warrants | ||||||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||||||
Sale of private placement warrants (in shares) | shares | 7,520,000 | |||||
Price of warrant | $ / shares | $ 1 | |||||
Proceeds from sale of Private Placement Warrants | $ 7,520,000 | |||||
IPO | ||||||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||||||
Number of units sold | shares | 27,600,000 | |||||
Purchase price, per unit | $ / shares | $ 10 | |||||
Proceeds from issuance initial public offering | $ 276,000,000 | |||||
Investment of cash into trust account | $ 276,000,000 | |||||
IPO | Class A common stock | ||||||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||||||
Number of shares in a unit | shares | 1 | |||||
IPO | Public Warrants | ||||||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||||||
Number of warrants in a unit | shares | 0.5 | |||||
Over-allotment option | ||||||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||||||
Number of units sold | shares | 3,600,000 | |||||
Purchase price, per unit | $ / shares | $ 10 | |||||
Related Party Loans | ||||||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||||||
Loan conversion agreement warrant | 1,500,000 | |||||
Sponsor | Working Capital Promissory Notes | ||||||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||||||
Maximum Borrowing Capacity of Related Party Promissory Note | $ 1,000,000 | |||||
Proceeds from Working Capital Promissory Notes | 1,000,000 | 375,000 | ||||
Fair value of outstanding balance | $ 60,000 | $ 169,000 |
SUMMARY OF SIGNIFICANT ACCOUN_4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Jan. 12, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||||||
Initial public offering costs | $ 16,316,186 | |||||
Transaction costs | 15,682,857 | |||||
Offering costs | $ 633,329 | $ 633,329 | ||||
Cash equivalents | $ 0 | $ 0 | $ 0 | |||
Statutory tax rate (as a percent) | 21% | 21% | 21% | 21% | ||
Unrecognized tax benefits | $ 0 | $ 0 | 0 | |||
Unrecognized tax benefits accrued for interest and penalties | $ 0 | $ 0 | $ 0 | |||
Anti-dilutive securities attributable to warrants (in shares) | 21,320,000 | |||||
Exercise price of warrant | $ 1 | $ 1 |
SUMMARY OF SIGNIFICANT ACCOUN_5
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Condensed Consolidated balance sheet (Details) - Class A common stock subject to possible redemption - USD ($) | 9 Months Ended | 12 Months Ended |
Sep. 30, 2022 | Dec. 31, 2021 | |
Gross proceeds | $ 276,000,000 | |
Proceeds Allocated to Public Warrants | (10,350,000) | |
Class A common stock issuance costs | (15,682,857) | |
Accretion of carrying value to redemption value | $ 988,853 | 26,032,857 |
Class A common stock subject to possible redemption | $ 276,988,853 | $ 276,000,000 |
SUMMARY OF SIGNIFICANT ACCOUN_6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Net Loss per Common Share (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Class A common stock | ||||
Numerator: | ||||
Allocation of net income (loss) | $ 906,660 | $ (93,048) | $ 8,368,967 | $ (925,590) |
Denominator | ||||
Basic weighted average shares outstanding | 27,600,000 | 27,600,000 | 27,600,000 | 26,391,241 |
Diluted weighted average shares outstanding | 27,600,000 | 27,600,000 | 27,600,000 | 26,391,241 |
Basic net income (loss) per common share | $ 0.03 | $ 0 | $ 0.30 | $ (0.04) |
Diluted net income (loss) per common share | $ 0.03 | $ 0 | $ 0.30 | $ (0.04) |
Class B common stock | ||||
Numerator: | ||||
Allocation of net income (loss) | $ 226,665 | $ (23,262) | $ 2,092,242 | $ (240,613) |
Denominator | ||||
Basic weighted average shares outstanding | 6,900,000 | 6,900,000 | 6,900,000 | 6,860,584 |
Diluted weighted average shares outstanding | 6,900,000 | 6,900,000 | 6,900,000 | 6,860,584 |
Basic net income (loss) per common share | $ 0.03 | $ 0 | $ 0.30 | $ (0.04) |
Diluted net income (loss) per common share | $ 0.03 | $ 0 | $ 0.30 | $ (0.04) |
INITIAL PUBLIC OFFERING (Detail
INITIAL PUBLIC OFFERING (Details) - $ / shares | Jan. 12, 2021 | Sep. 30, 2022 |
INITIAL PUBLIC OFFERING | ||
Exercise price of warrants | $ 1 | |
Public Warrants | Class A common stock | ||
INITIAL PUBLIC OFFERING | ||
Number of shares issuable per warrant | 1 | |
IPO | ||
INITIAL PUBLIC OFFERING | ||
Number of units sold | 27,600,000 | |
Purchase price, per unit | $ 10 | |
IPO | Class A common stock | ||
INITIAL PUBLIC OFFERING | ||
Number of shares in a unit | 1 | |
IPO | Public Warrants | ||
INITIAL PUBLIC OFFERING | ||
Number of warrants in a unit | 0.5 | |
Exercise price of warrants | $ 11.50 | |
Over-allotment option | ||
INITIAL PUBLIC OFFERING | ||
Number of units sold | 3,600,000 | |
Purchase price, per unit | $ 10 |
PRIVATE PLACEMENT (Details)
PRIVATE PLACEMENT (Details) - USD ($) | 9 Months Ended | |||||
Jan. 12, 2021 | Nov. 04, 2020 | Sep. 21, 2020 | Sep. 30, 2021 | Sep. 30, 2022 | Mar. 31, 2021 | |
Subsidiary, Sale of Stock [Line Items] | ||||||
Aggregate purchase price | $ 7,520,000 | |||||
Exercise price of warrant | $ 1 | |||||
Private Placement Warrants | ||||||
Subsidiary, Sale of Stock [Line Items] | ||||||
Number of warrants to purchase shares issued | 7,520,000 | |||||
Price of warrants | $ 1 | |||||
Aggregate purchase price | $ 7,520,000 | |||||
Private Placement Warrants | Sponsor | ||||||
Subsidiary, Sale of Stock [Line Items] | ||||||
Percentage of outstanding warrants | 7% | 20% | ||||
Private Placement | Private Placement Warrants | ||||||
Subsidiary, Sale of Stock [Line Items] | ||||||
Number of warrants to purchase shares issued | 7,520,000 | 7,520,000 | ||||
Price of warrants | $ 1 | |||||
Aggregate purchase price | $ 7,520,000 | |||||
Number of shares per warrant | 1 | |||||
Exercise price of warrant | $ 11.50 |
RELATED PARTY TRANSACTIONS - Fo
RELATED PARTY TRANSACTIONS - Founder Shares (Details) | 1 Months Ended | 9 Months Ended | ||||||
Jan. 07, 2021 shares | Nov. 17, 2020 D $ / shares | Nov. 04, 2020 shares | Sep. 21, 2020 shares | Sep. 17, 2020 USD ($) shares | Jan. 31, 2021 shares | Sep. 30, 2022 shares | Dec. 31, 2021 shares | |
Class B common stock | ||||||||
RELATED PARTY TRANSACTIONS | ||||||||
Common shares, shares issued | 6,900,000 | 6,900,000 | ||||||
Common shares, shares outstanding | 6,900,000 | 6,900,000 | ||||||
Founder Shares | ||||||||
RELATED PARTY TRANSACTIONS | ||||||||
Number of shares issued | 1,000 | |||||||
Membership interest converted | 5,000 | |||||||
Shares subject to forfeiture | 900,000 | |||||||
Percentage of issued and outstanding shares after the initial public offering collectively held by initial stockholders | 20% | |||||||
Founder Shares | Class B common stock | ||||||||
RELATED PARTY TRANSACTIONS | ||||||||
Shares issued upon on conversion | 1,000 | |||||||
Common shares, shares issued | 5,750,000 | |||||||
Common shares, shares outstanding | 6,900,000 | 5,750,000 | ||||||
Stock Split | 1.2 | |||||||
Aggregate number of shares owned | 1,150,000 | |||||||
Founder Shares | Sponsor | ||||||||
RELATED PARTY TRANSACTIONS | ||||||||
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares | $ 12 | |||||||
Founder Shares | Sponsor | Class B common stock | ||||||||
RELATED PARTY TRANSACTIONS | ||||||||
Aggregate number of shares owned | 4,600,000 | |||||||
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D | 20 | |||||||
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D | 30 | |||||||
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences | 150 days | |||||||
Founder Shares | Jefferies | ||||||||
RELATED PARTY TRANSACTIONS | ||||||||
Number of shares transferred | 100,625 | |||||||
Founder Shares | PNC Investment | ||||||||
RELATED PARTY TRANSACTIONS | ||||||||
Number of shares transferred | 301,875 | 1,150,000 | ||||||
Founder Shares | PNC Investment | Class B common stock | ||||||||
RELATED PARTY TRANSACTIONS | ||||||||
Aggregate purchase price | $ | $ 20,000 |
RELATED PARTY TRANSACTIONS - Ad
RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 9 Months Ended | |||||||||
Jan. 12, 2021 | Sep. 17, 2020 | Dec. 31, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Mar. 23, 2022 | Jan. 04, 2022 | Dec. 15, 2021 | Aug. 20, 2021 | Jan. 07, 2021 | |
RELATED PARTY TRANSACTIONS | ||||||||||||
Working capital promissory note | $ 1,000,000 | $ 1,000,000 | ||||||||||
Repayment of promissory note - related party | $ 128,302 | |||||||||||
Change in fair value of Working Capital Promissory Notes | 20,000 | $ 89,000 | 734,000 | 89,000 | ||||||||
Working capital loans warrant | ||||||||||||
RELATED PARTY TRANSACTIONS | ||||||||||||
Change in fair value of Working Capital Promissory Notes | 20,000 | 734,000 | ||||||||||
Promissory Note with Related Party | ||||||||||||
RELATED PARTY TRANSACTIONS | ||||||||||||
Maximum borrowing capacity of related party promissory note | $ 300,000 | |||||||||||
Repayment of promissory note - related party | $ 128,302 | |||||||||||
Administrative Support Agreement | ||||||||||||
RELATED PARTY TRANSACTIONS | ||||||||||||
Expenses per month | $ 10,000 | |||||||||||
Expenses incurred and paid | 29,211 | $ 29,211 | 87,633 | $ 77,896 | ||||||||
Related Party Loans | ||||||||||||
RELATED PARTY TRANSACTIONS | ||||||||||||
Loan conversion agreement warrant | 1,500,000 | 1,500,000 | ||||||||||
Related Party Loans | Working Capital Promissory Notes | ||||||||||||
RELATED PARTY TRANSACTIONS | ||||||||||||
Working capital promissory note | $ 400,000 | $ 275,000 | ||||||||||
Working capital loans | $ 225,000 | $ 100,000 | ||||||||||
Outstanding balance of related party note | $ 375,000 | $ 1,000,000 | $ 1,000,000 | |||||||||
Price of warrant | $ 1 | $ 1 | ||||||||||
Change in fair value of Working Capital Promissory Notes | $ 169,000 | $ 60,000 | ||||||||||
Sponsor | Working Capital Promissory Notes | ||||||||||||
RELATED PARTY TRANSACTIONS | ||||||||||||
Maximum borrowing capacity of related party promissory note | $ 1,000,000 | |||||||||||
PNC Investment | ||||||||||||
RELATED PARTY TRANSACTIONS | ||||||||||||
Working capital promissory note | $ 750,000 | 750,000 | ||||||||||
Jefferies | ||||||||||||
RELATED PARTY TRANSACTIONS | ||||||||||||
Working capital promissory note | $ 250,000 | $ 250,000 |
RELATED PARTY TRANSACTIONS - In
RELATED PARTY TRANSACTIONS - Initial Public Offering (Details) | Sep. 30, 2022 USD ($) | Dec. 31, 2021 USD ($) | Jan. 12, 2021 USD ($) |
RELATED PARTY TRANSACTIONS | |||
Underwriting fees | $ 5,520,000 | ||
Deferred underwriting fee payable | $ 9,660,000 | $ 9,660,000 | $ 9,660,000 |
Jefferies | |||
RELATED PARTY TRANSACTIONS | |||
Underwriting fees | 5,520,000 | ||
Solebury Capital LLC | |||
RELATED PARTY TRANSACTIONS | |||
Amount paid based on underwriting fees | $ 193,200 | ||
Solebury Capital LLC | Jefferies | |||
RELATED PARTY TRANSACTIONS | |||
Percentage of fees payable on gross spread earned by the underwriters | 3.5 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details) | Jan. 12, 2021 USD ($) item | Sep. 30, 2022 USD ($) $ / shares | Dec. 31, 2021 USD ($) |
COMMITMENTS AND CONTINGENCIES | |||
Number of holders securities entitled for demands on registration rights | 15% | ||
Maximum number of demands for registration of securities | item | 3 | ||
Deferred fee per unit | $ / shares | $ 0.35 | ||
Deferred underwriting fee payable | $ | $ 9,660,000 | $ 9,660,000 | $ 9,660,000 |
Maximum | Jefferies | |||
COMMITMENTS AND CONTINGENCIES | |||
Registration rights of securities term on demands | 7 years | ||
Minimum | Jefferies | |||
COMMITMENTS AND CONTINGENCIES | |||
Registration rights of securities term on demands | 5 years |
STOCKHOLDERS' DEFICIT - Preferr
STOCKHOLDERS' DEFICIT - Preferred Stock (Details) - $ / shares | Sep. 30, 2022 | Dec. 31, 2021 |
STOCKHOLDERS' DEFICIT | ||
Preferred shares, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, par value, (per share) | $ 0.0001 | $ 0.0001 |
Preferred shares, shares issued | 0 | 0 |
Preferred shares, shares outstanding | 0 | 0 |
STOCKHOLDERS' DEFICIT - Common
STOCKHOLDERS' DEFICIT - Common Stock (Details) | 9 Months Ended | |
Sep. 30, 2022 Vote $ / shares shares | Dec. 31, 2021 $ / shares shares | |
STOCKHOLDERS' DEFICIT | ||
Ratio to be applied to the stock in the conversion | 20 | |
Class A common stock subject to possible redemption | ||
STOCKHOLDERS' DEFICIT | ||
Class A common stock subject to possible redemption, issued (in shares) | 27,600,000 | 27,600,000 |
Class A common stock subject to possible redemption, outstanding (in shares) | 27,600,000 | 27,600,000 |
Class A common stock not subject to possible redemption | ||
STOCKHOLDERS' DEFICIT | ||
Common shares, shares authorized (in shares) | 200,000,000 | 200,000,000 |
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Common shares, votes per share | Vote | 1 | |
Class B common stock | ||
STOCKHOLDERS' DEFICIT | ||
Common shares, shares authorized (in shares) | 20,000,000 | 20,000,000 |
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Common shares, votes per share | Vote | 1 | |
Common shares, shares issued (in shares) | 6,900,000 | 6,900,000 |
Common shares, shares outstanding (in shares) | 6,900,000 | 6,900,000 |
WARRANTS (Details)
WARRANTS (Details) | 9 Months Ended | |
Sep. 30, 2022 D $ / shares shares | Dec. 31, 2021 shares | |
Warrants | ||
WARRANTS | ||
Maximum period after business combination in which to file registration statement | 15 days | |
Period of time within which registration statement is expected to become effective | 60 days | |
Private Placement Warrants | ||
WARRANTS | ||
Warrants outstanding | shares | 7,520,000 | 7,520,000 |
Public Warrants | ||
WARRANTS | ||
Warrants outstanding | shares | 13,800,000 | 13,800,000 |
Public warrants exercisable term after the completion of a business combination | 30 days | |
Public warrants exercisable term from the closing of the initial public offering | 12 months | |
Public warrants expiration term | 5 years | |
Threshold issue price per share | $ 9.20 | |
Warrant exercise price adjustment multiple | 115 | |
Public Warrants | Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00 | ||
WARRANTS | ||
Stock price trigger for redemption of public warrants (in dollars per share) | $ 18 | |
Redemption price per public warrant (in dollars per share) | $ 0.01 | |
Redemption period | 30 days | |
Threshold trading days for redemption of public warrants | D | 20 | |
Threshold consecutive trading days for redemption of public warrants | D | 30 | |
Threshold number of business days before sending notice of redemption to warrant holders | D | 3 | |
Public Warrants | Redemption of Warrants when the price per share of Class A common stock equals or exceeds $10.00 | ||
WARRANTS | ||
Stock price trigger for redemption of public warrants (in dollars per share) | $ 10 | |
Redemption price per public warrant (in dollars per share) | $ 0.10 | |
Minimum threshold written notice period for redemption of public warrants | 30 days |
FAIR VALUE MEASUREMENTS (Detail
FAIR VALUE MEASUREMENTS (Details) - USD ($) | 9 Months Ended | 12 Months Ended |
Sep. 30, 2022 | Dec. 31, 2021 | |
Assets: | ||
Investments held in Trust Account | $ 277,236,285 | $ 276,026,697 |
Liabilities: | ||
Working Capital Promissory Notes | 60,000 | 169,000 |
Warrant liabilities | 1,279,200 | 10,660,000 |
Cash withdrawn from Trust Account to pay franchise and income taxes | 382,865 | 0 |
Recurring | ||
Liabilities: | ||
Warrant liabilities | 1,279,200 | 10,660,000 |
Level 1 | Recurring | Public Warrants | ||
Liabilities: | ||
Warrant liabilities | 828,000 | 6,900,000 |
Level 1 | U.S. Treasury Securities Money Market Fund | Recurring | ||
Assets: | ||
Investments held in Trust Account | 277,236,285 | 276,026,697 |
Level 2 | Recurring | ||
Liabilities: | ||
Working Capital Promissory Notes | 60,000 | 169,000 |
Level 2 | Recurring | Private Placement Warrants | ||
Liabilities: | ||
Warrant liabilities | $ 451,200 | $ 3,760,000 |
FAIR VALUE MEASUREMENTS - Chang
FAIR VALUE MEASUREMENTS - Change in the Fair Value of Level 3 Warrant Liabilities (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||||
Sep. 30, 2022 | Sep. 30, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Jan. 12, 2021 | |
The changes in the fair value of Level 3 Warrant liabilities | |||||||
Fair value of Level 3 Warrant liabilities as of December 31,2021 | $ 1,279,200 | $ 1,279,200 | $ 10,660,000 | ||||
Fair value, measurement warrant liabilities transfers to/from | $ 0 | $ 0 | |||||
Level 3 | Warrants | |||||||
The changes in the fair value of Level 3 Warrant liabilities | |||||||
Initial measurement on January 12, 2021 | $ 15,990,000 | ||||||
Transfer to Level 1 during the three months ended March 31, 2021 | $ (10,350,000) | ||||||
Change in fair value of Private Placement Warrants from January 12 to June 30, 2021 | $ (75,200) | ||||||
Transfer to Level 2 during the three months ended September 30, 2021 | $ (5,564,800) | ||||||
Level 3 | Public Warrants | |||||||
The changes in the fair value of Level 3 Warrant liabilities | |||||||
Initial measurement on January 12, 2021 | 10,350,000 | ||||||
Transfer to Level 1 during the three months ended March 31, 2021 | (10,350,000) | $ (10,350,000) | |||||
Level 3 | Private Placement Warrants | |||||||
The changes in the fair value of Level 3 Warrant liabilities | |||||||
Initial measurement on January 12, 2021 | $ 5,640,000 | ||||||
Change in fair value of Private Placement Warrants from January 12 to June 30, 2021 | $ (75,200) | ||||||
Transfer to Level 2 during the three months ended September 30, 2021 | $ 5,564,800 | $ (5,564,800) |
FAIR VALUE MEASUREMENTS - Cha_2
FAIR VALUE MEASUREMENTS - Changes in the fair value of the Level 2 Working Capital Promissory Notes (Details) - USD ($) | 3 Months Ended | ||||
Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | |
FAIR VALUE MEASUREMENTS | |||||
Fair value at the period beginning | $ 80,000 | $ 190,000 | $ 169,000 | $ 186,000 | |
Proceeds received from Working Capital Promissory Notes | 625,000 | 100,000 | $ 275,000 | ||
Change in fair value | (20,000) | (110,000) | (604,000) | (117,000) | (89,000) |
Fair value at the period end | $ (60,000) | $ 80,000 | $ 190,000 | $ 169,000 | $ 186,000 |